Norbit ASA (NORBT)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 163.80 |
|---|---|
| 52-week range | 153.80 – 244.80 |
| Return, 1 month / 3 months | +1.4% / −4.7% |
| Return, 1 year / 3 years | −17.5% / +223.3% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -32.3% |
| Average daily value traded | 29.96M NOK |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Norbit is a Norwegian technology company based in Trondheim that develops and supplies products for identification, tracking and connectivity. Its range includes radio-frequency identification tags and readers, tracking devices for vehicles and assets, and marine electronics such as sonar and echo sounder systems. Customers come from transport, logistics, retail, maritime and defence markets, and the company serves them through its own product lines and specialist subsidiaries.
On this site Norbit ASA appears as a stock on the Oslo Børs (Norway), code NORBT, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Norbit ASA (NORBT) trades on the Oslo Børs in Norway. It last closed at NOK 163.80 on 27 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 191 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.5% and over the last three months it fell 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.6% | ||
| From 52-week high | -31.1% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.7% | ||
| 6-month return | -27.5% | ||
| 12-month return, skipping the last month | -18.6% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.3% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 29.96M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +1.4% |
| 3 months | −4.7% |
| 6 months | −27.5% |
| 1 year | −17.5% |
| 3 years | +223.3% |
| 5 years | +483.9% |
Signals
| 50-day / 200-day average | 161.32 / 181.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | NOK 5.0000 |
| 18 Nov 2025 | NOK 3.0000 |
| 7 May 2025 | NOK 3.0000 |
| 7 May 2024 | NOK 2.5500 |
| 5 May 2023 | NOK 0.7000 |
| 5 May 2022 | NOK 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.